Do DMARDs and biologic agents protect from cardiovascular disease in patients with inflammatory arthropathies?

被引：10

作者：

Atzeni, Fabiola ^{[1
]}

Svenungsson, Elisabet ^{[2
]}

Nurmohamed, Michael T. ^{[3
,4
]}

机构：

[1] Univ Messina, Rheumatol Unit, Messina, Italy

[2] Karolinska Inst, Karolinska Univ Hosp, Dept Med, Div Rheumatol, S-17172 Stockholm, Sweden

[3] Vrije Univ Amsterdam Med Ctr, Amsterdam Univ Med Ctr, Amsterdam Rheumatol Immunol Ctr, Amsterdam, Netherlands

[4] Reade Rheumatol, Amsterdam, Netherlands

来源：

AUTOIMMUNITY REVIEWS | 2019年 / 18卷 / 12期

关键词：

Rheumatoid arthritis; Inflammatory arthropathies; Cardiovascular disease; Disease modifying antirheumatic drugs (DMARDS); Biologic treatment; SEROPOSITIVE RHEUMATOID-ARTHRITIS; CONGESTIVE-HEART-FAILURE; NECROSIS-FACTOR-ALPHA; MYOCARDIAL-INFARCTION; EXCESS MORTALITY; LIPID PROFILE; THERAPY; RISK; IMPROVEMENT; COHORT;

D O I：

10.1016/j.autrev.2019.102401

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

071005 [微生物学]; 100108 [医学免疫学];

摘要：

[No abstract available]

引用

页数：5

共 46 条

[1]

Rheumatoid arthritis and excess mortality: down but not out. A primary care cohort study using data from Clinical Practice Research Datalink [J].

Abhishek, Abhishek ;

Nakafero, Georgina ;

Kuo, Chang-Fu ;

Mallen, Christian ;

Zhang, Weiya ;

Grainge, Matthew J. ;

Doherty, Michael .

RHEUMATOLOGY, 2018, 57 (06) :977-981

[2]

EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update [J].

Agca, R. ;

Heslinga, S. C. ;

Rollefstad, S. ;

Heslinga, M. ;

McInnes, B. ;

Peters, M. J. L. ;

Kvien, T. K. ;

Dougados, M. ;

Radner, H. ;

Atzeni, F. ;

Primdahl, J. ;

Sodergren, A. ;

Jonsson, S. Wallberg ;

van Rompay, J. ;

Zabalan, C. ;

Pedersen, T. R. ;

Jacobsson, L. ;

de Vlam, K. ;

Gonzalez-Gay, M. A. ;

Semb, A. G. ;

Kitas, G. D. ;

Smulders, Y. M. ;

Szekanecz, Z. ;

Sattar, N. ;

Symmons, D. P. M. ;

Nurmohamed, M. T. .

ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 (01) :17-28

[3]

Low-dose prednisolone treatment of early rheumatoid arthritis and late cardiovascular outcome and survival: 10-year follow-up of a 2-year randomised trial [J].

Ajeganova, Sofia ;

Svensson, Bjorn ;

Hafstrom, Ingiald .

BMJ OPEN, 2014, 4 (04)

[4]

Alpha S., 2017, OLUMIANT CLOT SIGNAL

[5]

Mortality profile of patients with rheumatoid arthritis in France and its change in 10 years [J].

Avouac, Jerome ;

Amrouche, Fazia ;

Meune, Christophe ;

Rey, Gregoire ;

Kahan, Andre ;

Allanore, Yannick .

SEMINARS IN ARTHRITIS AND RHEUMATISM, 2017, 46 (05) :537-543

[6]

Benucci M, 2013, CLIN EXP RHEUMATOL, V31, P322

[7]

Benucci, Maurizio ;

Saviola, Gianantonio ;

Manfredi, Mariangela ;

Sarzi-Puttini, Piercarlo ;

Atzeni, Fabiola .

BIOLOGICS-TARGETS & THERAPY, 2013, 7 :69-75

[8]

Trends in the epidemiology of cardiovascular disease in the UK [J].

Bhatnagar, Prachi ;

Wickramasinghe, Kremlin ;

Wilkins, Elizabeth ;

Townsend, Nick .

HEART, 2016, 102 (24) :1945-1952

[9]

Effects of tofacitinib and other DMARDs on lipid profiles in rheumatoid arthritis: implications for the rheumatologist [J].

Charles-Schoeman, Christina ;

Gonzalez-Gay, Miguel A. ;

Kaplan, Irina ;

Boy, Mary ;

Geier, Jamie ;

Luo, Zhen ;

Zuckerman, Andrea ;

Riese, Richard .

SEMINARS IN ARTHRITIS AND RHEUMATISM, 2016, 46 (01) :71-80

[10]

Association of Triple Therapy With Improvement in Cholesterol Profiles Over Two-Year Followup in the Treatment of Early Aggressive Rheumatoid Arthritis Trial [J].

Charles-Schoeman, Christina ;

Wang, Xiaoyan ;

Lee, Yuen Yin ;

Shahbazian, Ani ;

Navarro-Millan, Iris ;

Yang, Shuo ;

Chen, Lang ;

Cofield, Stacey S. ;

Moreland, Larry W. ;

O'Dell, James ;

Bathon, Joan M. ;

Paulus, Harold ;

Bridges, S. Louis, Jr. ;

Curtis, Jeffrey R. .

ARTHRITIS & RHEUMATOLOGY, 2016, 68 (03) :577-586

← 1 2 3 4 5 →